SEARCH

SEARCH BY CITATION

References

  • 1
    Task Force on Pulmonary Embolism European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J. 2000; 21: 130136.
  • 2
    Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism. Arch Intern Med 2000; 160: 76168.
  • 3
    Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17: 25970.
  • 4
    Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism: a statement for healthcare professionals. Circulation 1996; 93: 221245.
  • 5
    Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. Lancet 1960; 130912.
  • 6
    Nielsen HK, Husted SE, Krusell LR, Fasting H, Charles P, Hansen HH. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med 1994; 235: 45761.
  • 7
    Nielsen HK, Husted SE, Krusell LR et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thromb Res 1994; 73: 21526.
  • 8
    Levine MN, Raskob G, Landefeld S, Kearon C. Haemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 108S21S.
  • 9
    Cundiff DK. Does anticoagulant treatment reduce the mortality of acute pulmonary embolism? Arch Intern Med 2001; 161: 2148.
  • 10
    Egermayer P. Value of anticoagulants in the treatment of pulmonary embolism: a discussion paper. J R Soc Med 1981; 74: 67581.
  • 11
    Lowe GD, Prentice CR. Thrombosis. In: BowieEJ, ed. Haemostasis and Thrombosis. London: Butterworths, 1985; 284318.
  • 12
    Killewich LA, Bedford GR, Beach KW, Strandness DE. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9: 8997.
  • 13
    Krupski WC, Bass A, Dilley RB, Bernstein EF, Otis SM. Propagation of deep venous thrombosis identified by duplex ultrasonography. J Vasc Surg 1990; 12: 46775.
  • 14
    Meissner MH, Caps MT, Bergelin RO, Manzo RA, Strandness DE. Propagation, rethrombosis and new thrombus formation after acute deep venous thrombosis. J Vasc Surg 1995; 22: 55867.
  • 15
    Wells PS, Forster AJ. Thrombolysis in deep vein thrombosis: is there still an indication? Thromb Haemost 2001; 86: 499508.
  • 16
    Wells PS, Ginsberg JS, Anderson DR et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129: 9971005.
  • 17
    Dalen JE. When can treatment be withheld in patients with suspected pulmonary embolism? Arch Intern Med 1993; 153: 14158.
  • 18
    Hull RD, Pineo GF. Disorders of Thrombosis. Philadelphia: WB Saunders Company, 1995.
  • 19
    Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postoperative deep vein thrombosis. Lancet 1969; 2302.
  • 20
    Doyle DJ, Turpie AG, Hirsh J. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. Ann Intern Med 1987; 107: 4415.
  • 21
    Hirsh J, Hull RD, Raskob GE. Diagnosis of pulmonary embolism. JACC 1986; 8: 128B36B.
  • 22
    Hull RD, Raskob GE, Ginsberg JS et al. A non-invasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med 1994; 154: 28997.
  • 23
    Raskob GE. Calf-vein thrombosis. In: HullR, RaskobG, PineoG, eds. Venous Thromboembolism: an Evidence-based Atlas. Armonk, NY: Futura Publishing Co., 1996; 30713.
  • 24
    Salzman EW. Venous thrombosis made easy. New Engl J Med 1986; 314: 8478.
  • 25
    Stein PD, Hull RD, Raskob GE. Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial non-invasive leg tests. Am J Med 2000; 109: 3016.
  • 26
    Hull RD, Raskob GE, Pineo GF, Brant RF. The low-probability lung scan. Arch Intern Med 1995; 155: 184551.
  • 27
    Philbrick JT, Becker DM. Calf deep venous thrombosis. A wolf in sheep's clothing. Arch Intern Med 1988; 148: 21318.
  • 28
    Moser KM, LeMoine JR. Is embolic risk conditioned by location of post-operative deep vein thrombosis? Ann Intern Med 1981; 94: 43944.
  • 29
    Douss TW. The clinical significance of venous thrombosis of the calf. Br J Surg 1976; 63: 3778.
  • 30
    Solis MM, Ranval TJ, Nix ML et al. Is anticoagulation indicated for asymptomatic postoperative calf vein thrombosis? J Vasc Surg 1992; 16: 4149.
  • 31
    Clarke-Pearson DL, Synan IS, Coleman RE, Hinshaw W, Creasman WT. The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol 1984; 148: 10514.
  • 32
    Giannoukas AD, Labropoulos N, Burke P, Katsamouris A, Nicolaides AN. Calf deep venous thrombosis: a review of the literature. Eur J Vasc Endovasc Surg 1995; 10: 398404.
  • 33
    ACCP Consensus Committee on Pulmonary Embolism. Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest 1996; 109: 2337.
  • 34
    Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S75S.
  • 35
    Cogo A, Lensing AW, Prandoni P, Hirsh J. Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Arch Intern Med 1993; 153: 277780.
  • 36
    Mannucci PM, Poller L. Historical review: venous thrombosis and anticoagulant therapy. Br J Haem 2001; 114: 25870.
  • 37
    Ramsay LE. Impact of venography on the diagnosis and management of deep vein thrombosis. BMJ 1983; 286: 6989.
  • 38
    Simpson FG, Robinson PJ, Bark M, Losowsky MS. Prospective study of thrombophlebitis and ‘pseudothrombophlebitis’. Lancet 1980; 1: 3313.
  • 39
    Stein PD. Changing patterns of risk of untreated thromboembolic disease. Semin Resp Crit Care Med 1996; 17: 36.
  • 40
    Morris GK. Anticoagulants and venous thromboembolism. In: MeadeTW, ed. Anticoagulants and Myocardial Infarction: a Reappraisal. Norwich: John Wiley & Sons, 24362.
  • 41
    Antiplatelet Trialist's Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 23546.
  • 42
    Pulmonary Embolism Prevention Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295302.
  • 43
    Hermann RE, Davis JH, Holden WD. Pulmonary embolism: a clinical and pathological study with emphasis on the effect of prophylactic therapy with anticoagulants. Am J Surg 1961; 102: 1928.
  • 44
    Sacks H, Chalmers TC, Smith H. Randomised versus historical controls for clinical trials. Am J Med 1982; 72: 23340.
  • 45
    Goldman L, Sayson R, Robbins S, Cohn LH, Bettman M, Weisberg M. The value of the autopsy in three medical eras. New Engl J Med 1983; 308: 10005.
  • 46
    Morpurgo M, Schmid C. The spectrum of pulmonary embolism. Chest 1995; 107: 18S20S.
  • 47
    Karwinski B, Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol 1989; 42: 1359.
  • 48
    Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 97881.
  • 49
    Mandelli V, Schmid C, Zogno C, Morpurgo M. ‘False negative’ and ‘false positives’ in acute pulmonary embolism: a clinical-postmortem comparison. Cardiologia 1997; 42: 20510.
  • 50
    Coon WW, Coller FA. Clinicopathologic correlation in thromboembolism. Surg Gynecol Obstetr 1959; 109: 25969.
  • 51
    Gorham LW. A study of pulmonary embolism. Arch Intern Med 1961; 108: 7690.
  • 52
    Donaldson GA, Williams C, Scannell JG, Shaw RS. A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. New Engl J Med 1963; 268: 1714.
  • 53
    Heit JA, Silverstein MD, Mohr DN et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 45263.
  • 54
    Carson JI, Kelley MA, Duff A et al. The clinical course of pulmonary embolism. New Engl J Med 1992; 326: 12405.
  • 55
    Jorpes JE. Anticoagulant therapy in thrombosis. Surg Gyn Obstetr 1947; 84: 67781.
  • 56
    Takats G, Jesser JH. Pulmonary embolism. JAMA 1940; 114: 141521.
  • 57
    Barker NW, Priestley JT. Postoperative thrombophlebitis and embolism. Surgery 1942; 4112.
  • 58
    Anonymous. Thromboembolism. Am J Med 1947; 3: 75368.
  • 59
    Marks J. Treatment of venous thrombosis with anticoagulants. Lancet 1954; ii: 78791.
  • 60
    Murray G. Anticoagulant therapy with heparin. Am J Med 1947; 3: 46871.
  • 61
    Anlyan WG, Hart D. Special problems in venous thromboembolism. Ann Surgery 1957; 146: 499509.
  • 62
    Allen EV, Hines EA, Kvale WF, Barker NW. The use of dicumarol as an anticoagulant: experience in 2307 cases. Ann Intern Med 1959; 27: 37181.
  • 63
    Fuller CH, Robertson CW, Smithwick RH. Management of thromboembolic disease. New Engl J Med 1960; 263: 9837.
  • 64
    Morrell MT, Truelove SC, Barr A. Pulmonary embolism. BMJ 1963; 2: 8305.
  • 65
    Bauer, G. Clinical experience of a surgeon in the use of heparin. Am J Cardiol 1963; 14: 2935.
  • 66
    Browse NL, Thomas ML, Solan MJ, Young AE. Prevention of recurrent pulmonary embolism. BMJ 1969; 3: 3836.
  • 67
    Coon WW, Willis PW, Symons MJ. Assessment of anticoagulant treatment of venous thromboembolism. Ann Surgery 1969; 170: 55967.
  • 68
    Bauer G. Early diagnosis of venous thrombosis by means of venography and abortive treatment with heparin. Acta Med Scand 1941; 57: 13647.
  • 69
    Bauer, G. Early diagnosis and abortive treatment with heparin. Lancet 1946; I: 44754.
  • 70
    Zilliacus H. On the specific treatment of thrombosis and pulmonary embolism with anticoagulants, with a particular reference to the post thrombotic sequelae. Acta Med Scand 1946; 170: 1221.
  • 71
    Barker NW, Hines EA, Kvale WF, Allen EV. Dicumarol. Am J Med 1947; 3: 63442.
  • 72
    Ball KP, Hughes HO. Venous thrombosis and anticoagulants. BMJ 1949; i: 5605.
  • 73
    Sevitt S, Gallagher N. Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet 1959; 9819.
  • 74
    Byrne JJ. Phlebitis: a study of 979 cases at the Boston City Hospital. JAMA 1960; 174: 97101.
  • 75
    Kim Y, Kim J. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg 2002; 84-B: 56670.
  • 76
    Lassen MR, Borris LC. Prevention in orthopaedic surgery and trauma. In: HullR, PineoGF, eds. Disorders of Thrombosis. Philadelphia: W.B Saunders Company, 1996; 20915.
  • 77
    Pellegrini VD, Langhans MJ, Totterman S, Marder VJ, Francis CW. Embolic complications of calf thrombosis following total hip arthroplasty. J Arthroplasty 1993; 8: 44956.
  • 78
    Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Ann Surg 1988; 208: 22740.
  • 79
    Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 45862.
  • 80
    Comerota AJ, Katz ML, Grossi RJ et al. The comparative value of non-invasive testing for diagnosis and surveillance of deep vein thrombosis. J Vasc Surg 1988; 7: 409.
  • 81
    Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Predictors of survival after deep vein thrombosis and pulmonary embolism. Arch Intern Med 1999; 159: 44553.
  • 82
    Stein PD, Henry JW, Relyea B. Untreated patients with pulmonary embolism. Chest 1995; 107: 9315.
  • 83
    The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 27539.
  • 84
    Johnson R, Charnley J. Treatment of pulmonary embolism in total hip replacement. Clin Orthopaed Relat Res 1977; 124: 14954.
  • 85
    Stein PD, Hull RD, Pineo G. Strategy that includes serial noninvasive leg tests for diagnosis of thromboembolic disease in patients with suspected acute pulmonary embolism based on data from PIOPED. Arch Intern Med 1995; 155: 21014.
  • 86
    Hambleton J. Anticoagulation in high-risk patients: when is this approach not worth the risk? Am J Med 2000; 109: 3357.
  • 87
    Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000; 160: 34316.
  • 88
    Anonymous. The urokinase pulmonary embolism trial. Circulation 1973; 58 (S11): ii66ii72.
  • 89
    Alpert JS, Smith R, Carlson J, Ockene IS, Dexter L, Dalen JE. Mortality in patients treated for pulmonary embolism. JAMA 1976; 236: 147780.
  • 90
    Morpurgo M, Schmid C. Clinico-pathological correlations in pulmonary embolism: a posterior evaluation. Prog Resp Res 1980; 13: 815.
  • 91
    Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. NEJM 1988; 116273.
  • 92
    Mismetti P, Laporte-Simitsidis S, Tardy B et al. Prevention of venous thromboembolism in internal medicine with unfractionated of low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000; 83: 1419.
  • 93
    Pinede L, Duhaut P, Cucherat M, Ninet J, Pasquier J, Boissel JP. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials. J Intern Med 2000; 247: 55362.
  • 94
    Prins MH, Marchiori A. Risk of recurrent venous thromboembolism – expanding the frontier. Thromb Haemost 2002; 87: 13.
  • 95
    Levine MN, Hirsh J, Gent M et al. Optimal duration of oral anticoagulation therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 60611.
  • 96
    Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New Engl J Med 1999; 340: 9017.
  • 97
    Schulman S, Rhedin AS, Lindmarker P et al. and the Duration of Anticoagulation Trial Study Group. New Engl J Med 1995; 332: 16615.
  • 98
    Schulman S, Granqvist S, Holmstrom M et al. and The Duration of anticoagulation Trial Study Group. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New Engl J Med 1997; 336: 3938.
  • 99
    Hull RD, Raskob GE, Hirsh J et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. New Engl J Med 1986; 315: 110914.
  • 100
    Hull RD, Delmore T, Genton E et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. New Engl J Med 1979; 301: 8558.
  • 101
    Brandjes DP, Heijboer H, Buller HR, de Rijk M, Jagt H, ten Cate JW. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. New Engl J Med 1992; 327: 14859.
  • 102
    Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. New Engl J Med 1972; 287: 3247.
  • 103
    Coon WW, Willis PW. Recurrence of venous thromboembolism. Surgery 1973; 73: 8237.
  • 104
    Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a ‘standard care’ nomogram. Ann Intern Med 1993; 119: 87481.
  • 105
    White RH, Beyth RJ, Zhou H, Romano PS. Major bleeding after hospitalisation for deep venous-thrombosis. Am J Med 1999; 107: 41424.
  • 106
    Fraser DG, Moody AR, Morgan PS Martel AL, Davidson I. Diagnosis of lower limb deep venous thrombosis (DVT): a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002; 136: 8998.
  • 107
    Moody AR, Wastie M, Gregson R, Whitaker SC. Diagnostic accuracy of direct MR imaging of pulmonary emboli compared to conventional pulmonary angiography. Radiographics 1997; Abstract. no. 205: 268.
  • 108
    Moody AR, Liddicoat A, Krapup K. Pulmonary angiography and direct magnetic resonance imaging of embolus for the detection of pulmonary embolism. Invest Radiol 1997; 32: 43140.
  • 109
    Fraser DG, Moody AR, Martel A, Morgan P. Determinants of pulmonary embolism in patients presenting with deep venous thrombosis: prospective study using magnetic resonance direct thrombus imaging. Abstract from the European Haematology Association 5th Congress. 2000: 1323.